Healthtech Startups

0 investors

0 investors

Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable. The company focuses on precision antibiotics to address antimicrobial resistance, combining synthetic biology, robotics, and data science.

0 investors

0 investors

Biophyx Surgical develops surgical retraction technologies, working with surgeons and stakeholders to create medical devices aimed at improving surgical outcomes. The company operates in the surgical medical device sector, drawing on experience in device R&D, regulatory, and intellectual property.

0 investors

bioProtonics develops Magnetic Resonance Histopathology (MRH), an MRI-based software method that non-invasively measures tissue microstructure at a sub-millimeter level to help radiologists detect early signs of cancer and other diseases. The technology integrates with standard MRI scans and DICOM workflows and uses AI analysis as a "digital biopsy" aimed at reducing reliance on surgical biopsies.

0 investors

BioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.

0 investors

BioRegenx develops hardware and software for microscopy imaging of the endothelial glycocalyx, along with microvascular regenerative products, serving doctors, research scientists, and wellness consumers. The company combines diagnostic imaging technology with regenerative therapeutics in the medical device and wellness sector.

0 investors

BioRestorative Therapies develops cell- and tissue-based therapeutic products, primarily using adult stem cells, targeting conditions such as degenerative disc disease and metabolic disorders. It also runs a BioCosmeceutical platform applying secretome-based biologics to aesthetic medicine, and is a publicly traded company (NASDAQ:BRTX).

0 investors

Bioscape Digital provides bedside patient-engagement technology for hospitals and healthcare facilities, including tablets and touch-screen tools for real-time patient feedback, education, staff rounding documentation, and rehab scheduling. Its systems aim to improve patient satisfaction, care compliance, and infection control while reducing PPE use, risk, and cost.

0 investors

Option Care Health provides infusion therapy services for patients with a range of acute and chronic conditions, working with healthcare providers, health systems, hospitals, insurers, and pharmaceutical manufacturers. It positions itself as the largest national independent provider of infusion therapy in the United States.

0 investors

0 investors

Streamex Corp. operates a blockchain-based platform for tokenizing real-world assets, beginning with GLDY, a digital token backed by physical gold held in a Cayman Islands special purpose vehicle with yield generated through gold leasing; the company also maintains a legacy medical device business developing advanced signal processing software for cardiac electrophysiology applications.

0 investors

BioStem Technologies develops human amniotic membrane allograft products for advanced surgical care and wound care, used as adjunct treatments for chronic and acute wounds. Its offerings use cryopreserved, hydrated, and dehydrated membrane technologies for clinical and veteran patient populations.

0 investors

Biostream Technologies develops interactive, evidence-based adjunctive therapies for children with autism, designed to improve eye contact, visual behavior, attention, and emotion recognition. The company serves therapists and special education professionals treating autistic children.

0 investors

Biothea Pharma develops a needle-free treatment for severe allergic reactions and anaphylaxis, intended as a convenient, lower-cost alternative to existing products. It operates in the pharmaceutical/biotech industry focused on allergic emergency care.

0 investors

0 investors

Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.

0 investors

BioTuring is a bioinformatics company that builds algorithms and software for analyzing biological data, including single-cell and genomic data. It serves the global scientific research community working to understand biology and improve human health.

0 investors

Biovision Diagnostics operates a clinical diagnostic laboratory providing medical testing services to healthcare providers and organizations, focusing on faster turnaround times, proprietary testing methods, and competitive pricing. It serves clients and their patients through lab services intended to improve diagnostic quality.

0 investors

0 investors

Bioxytran is a clinical-stage pharmaceutical company developing carbohydrate-based drug platforms in glycovirology, hypoxia, and degenerative diseases, using galectin inhibitors to block viral replication and oxygen-carrying treatments for conditions such as stroke, wounds, and brain damage. Its therapies target viruses, hypoxic conditions, necrosis, and degenerative diseases.

0 investors

BiPAD Surgical provides surgical and operating room equipment, including touchscreen devices (BiPAD Touch) and electrosurgical units such as the Medtronic Valleylab ESU. It serves hospitals and surgical suites with medical hardware for use in operating rooms.

0 investors

0 investors